AMAG Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$6.4 |
Market Cap |
$337.67 M |
Shares Outstanding |
33.77 M |
Public Float |
33.53 M |
Address |
1100 Winter Street Waltham Massachusetts 02451 United States |
Employees | - |
Website | http://www.amagpharma.com |
Updated | 07/08/2019 |
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the research, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. |